Glizid-M XR 30 Tablet
By Glizid-M
Rx
10 Tablet ER in a Strip

Composition
Gliclazide(30mg) + Metformin(500mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
September, 2026

liver
When taking Glizid-M XR 30 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is advised to consult with your doctor before starting treatment with Glizid-M XR 30 Tablet. Typically, in individuals with mild to moderate liver disease, the medication is initiated at a low dose. However, it is not recommended for use in patients with severe liver disease. Always seek guidance from your healthcare provider when considering the use of Glizid-M XR 30 Tablet.

kidney
Glizid-M XR 30 Tablet should be used cautiously in patients with kidney disease. Adjusting the dose may be necessary, and it is not recommended for those with severe kidney issues. Regularly monitor kidney function tests while on this medication.

alcohol
It is not safe to drink alcohol while taking Glizid-M XR 30 Tablet. Consult your doctor when consuming alcohol with this medication.

driving
When taking Glizid-M XR 30 Tablet, avoid driving if experiencing low or high blood sugar symptoms that may impair focus or reaction time.

pregnancy
Glizid-M XR 30 Tablet should not be used during pregnancy as it poses risks to the developing baby. However, in rare life-threatening cases, a doctor may prescribe it if the benefits outweigh the potential risks. It is crucial to consult your doctor before use.

breastfeeding
Caution should be taken while breastfeeding and using Glizid-M XR 30 Tablet, as limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹91.35
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024